A perspective on monoclonal antibody therapy: Where we have been and where we are going

Seminars in Hematology

Volumn 37, Issue 4 SUPPL. 7, 2000, Pages 43-46

  Levy, Ronald ^a,b  

^a STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b STANFORD UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD20 ANTIGEN; CD40 ANTIGEN; COMPLEMENTARY DNA; MONOCLONAL ANTIBODY; RITUXIMAB;

ANTINEOPLASTIC ACTIVITY; CANCER IMMUNOLOGY; CANCER IMMUNOTHERAPY; CLINICAL TRIAL; CONFERENCE PAPER; DRUG DESIGN; DRUG TARGETING; HUMAN; IMMUNOMODULATION; LYMPHOMA; MEDICAL RESEARCH; PRIORITY JOURNAL;

EID: 0033794669     PISSN: 00371963     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0037-1963(00)90059-3     Document Type: Conference Paper

References (17)

1. Distinct types of diffuse large B-cell lymphoma identified by gene expression profiling
2. Association of serum Rituximab (IDEC-C2B8) concentration and anti-tumor response in the treatment of recurrent low-grade or follicular non-Hodgkin's lymphoma
3. Inhibitory Fc receptors modulate in vivo cytotoxicity against tumor targets
4. Therapy of B-cell lymphoma with anti-CD20 antibodies can result in the loss of CD20 antigen expression
5. Final report on the safety and efficacy of retreatment with rituximab for patients with non-Hodgkin's lymphoma
6. Use of a cDNA microarray to analyse gene expression patterns in human cancer
7. CD40 antibody evokes a cytotoxic T-cell response that eradicates lymphoma and bypasses T-cell help
8. CD20-negative relapse in B-cell lymphoma after treatment with Rituximab
9. Lymphocytic lymphomas
10. IDEC-C2B8: Results of a phase I multiple-dose trial in patients with relapsed non-Hodgkin's lymphoma
11. Rituximab chimeric anti-CD20 monoclonal antibody therapy for relapsed indolent lymphoma: Half of patients respond to a four-dose treatment program
12. Mice carrying a CD20 gene disruption
13. Quantitative monitoring of gene expression patterns with a complementary DNA microarray
14. A DNA microarray system for analyzing complex DNA samples using two-color fluorescent probe hybridization
15. + T-cell tolerance to T-cell priming through in vivo ligation of CD40
16. Characterization of a human B lymphocyte-specific antigen
17. CD20: A regulator of cell-cycle progression of B lymphocytes